Dr. C. Brock Woodis

Associate Professor of Pharmacy Practice

Ambulatory Care

Associated Faculty, Doctor of Physical Therapy Program

Pharm.D., Auburn University

[email protected]

Location: Duke University Medical Center

Academic Experience Summary
Dr. Woodis is a board-certified pharmacotherapy specialist (BCPS) as well as a board-certified ambulatory care pharmacist (BCACP) through the Board of Pharmacy Specialties.  He is also board-certified in advanced diabetes management (BC-ADM) through the American Association of Diabetes Educators.  He practices as a Clinical Pharmacist Practitioner, a recognized credential by both North Carolina Medical and Pharmacy Boards, at Duke Family Medicine (DFM) in Durham, North Carolina.  In this role, he holds prescribing privileges through a collaborative practice agreement with his supervising physician.  Dr. Woodis provides pharmacist-managed outpatient/ambulatory care pharmacotherapy services including diabetes mellitus, hypertension, and dyslipidemia at DFM.  In addition to coordinating the Women’s Health elective and teaching in the Campbell University College of Pharmacy & Health Sciences Doctor of Pharmacy program, Dr. Woodis also provides several lectures to the Physician Assistant programs at both Campbell University and Duke University.

• Bachelor of Science, Biology, University of Alabama at Birmingham, Birmingham, AL, 2001
• Doctor of Pharmacy, Auburn University, Auburn, AL, 2005
• Postgraduate-Year 1 Pharmacy Residency, Wake Forest University Baptist Medical Center, Winston-Salem, NC, 2006
• Postgraduate-Year 2 Pharmacy Residency, Family Medicine/Pharmacotherapy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC, 2007

Professional Memberships
• North Carolina Association of Pharmacists
• American-Society of Health-System Pharmacists
• American Association of Colleges of Pharmacy

Research Interests
My research interests include:
• Clinical pharmacist practitioner impact on diabetes mellitus outcomes
• Clinical pharmacist practitioner impact on hepatitis B vaccination rates
• Clinical pharmacist practitioner impact on vitamin d deficiency identification and treatment

Peer-Reviewed Journal Publications
Selected Publications include:

  • McLendon AN and Woodis CB.  A review of osteoporosis management in younger, premenopausal women. [accepted for publication on October 24, 2013 and slated for publication in the January 2014 issue of Women’s Health].
  • McLendon AN, Spivey JR, Woodis CB. African mango (Irvingia gabonensis) extract for weight loss: A systematic review. Journal of Nutritional Therapeutics 2013;2:53-58.
  • Woodis CB, Fuentes D, Sease L. De-escalation of antipsychotic medications in an elderly patient with alzheimer’s dementia residing in an assisted living facility. The Mental Health Clinician (MHC). 2012 November. Available at http://cpnp.org/resource/mhc/2012/11/de-escalation-antipsychotic-medications-elderly-patient-alzheimers-dementia. Accessed November 5, 2012.
  • Woodis CB, McLendon AN, Muzyk AJ.  Testosterone supplementation for hypoactive sexual desire disorder (HSDD) in women.  Pharmacotherapy 2012;32:38–53.
  • Bates JB, Buie LW, Woodis CB.  Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.  Pharmacotherapy     2011;31:1092–1110.
  • Patel M and Woodis CB.  CPP opportunities for the new practitioner/a new practitioner’s experience in becoming a CPP. North Carolina Pharmacist Fall 2011;91:21.
  • Woodis CB.  OB-GYN Disorders and Women’s Health.  Section editor and case writer.  In: Ginsburg DB.  ASHP’s PharmPrep: Interactive Case-based Board Review, 4th ed.  Bethesda: American Society of Health-System Pharmacists, 2011. Online version: updated annually. www.pharmpreponline.com.
  • Woodis CB. New Practitioner Spotlight: C. Brock Woodis. North Carolina Pharmacist Fall 2010;90:18.
  • Woodis CB.  Hormone therapy for the management of menopausal symptoms: pharmacotherapy   update. Journal of Pharmacy Practice 2010;23:540-7.
  • Karwa R and Woodis CB. Midodrine and octreotide in the treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother 2009;43:692-699. 
  • Woodis CB.  Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.  Ann Pharmacother 2008;42:1085-9.
  • Woodis CB.  Solifenacin succinate (Vesicare) Formulary Evaluation. Part 2 of 2.  Drug Criteria and Outcomes: Supplement to Drug Formulary Review 2005:21 (Suppl 4):1-4.
  • Woodis CB.  Solifenacin succinate (Vesicare) Formulary Evaluation. Part 1 of 2.  Drug Criteria and Outcomes: Supplement to Drug Formulary Review 2005;21 (Suppl 3):1-4.
  • Woodis CB.  Spotlight on the 5-HT3 antagonist Aloxi® (palonosetron). AlSHP Newsletter 2004; 29(4)6-7.
  • Woodis CB, Johnson JJ, and Pegram PS. Use of total bilirubin to assess medication adherence to atazanavir.  American Society of Health-System Pharmacists Midyear Clinical Meeting. Dec 2006.

Are you an alumnus? Connect with us.

Visit Our Alumni Website ››

Upcoming Events

View Calendar

There are not any events currently scheduled.

Connect With Us